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INTRODUCTION
Vogt-Koyanagi-Harada (VKH) disease is considered a bilateral, gra-
nulomatous panuveitis associated with central nervous system, auditory,
and integumentary manifestations. It initially manifests with prodromal
symptoms similar to aseptic meningitis, followed by posterior uveitis with
exudative retinal detachments and disc hyperemia(1). VKH disease is thou-
ght to be a T-cell-mediated autoimmune process directed against one or
more antigenic components of melanocytes, a cell shared by the involved
regions(2). The disease occurs more frequently in pigmented groups, it is
likely that certain ethnic groups have genetic backgrounds that predispose
them to VKH disease. Specific human leucocyte antigen (HLA) types have
been reported to be associated with the disease. Findings from different
parts of the world indicate that there is an association between class II,
subtype DR4 HLA and VKH disease, especially the HLA-DRB1*0405
allele(3). The precise cause of the disease is uncertain, but T-lymphocyte-
mediated autoimmunity directed against melanocytes is likely to play an
important role(4).
There are no specific diagnostic tests for VKH disease. At present, the
diagnosis is usually made based on the clinical findings of prodromal CNS
findings followed by a bilateral exudative posterior uveitis(5). In addition the
disease could have ocular and extraocular symptoms, only extraocular or
only ocular symptoms.
The typical treatment for VKH disease is high-dose corticosteroid the-
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Purpose: To determine the applicability of the international revised
diagnostic criteria for Vogt-Koyanagi-Harada disease. Methods: Re-
trospective study. Medical charts of 140 patients with the diagnosis of
Vogt-Koyanagi-Harada disease, from the Uveitis Sector of the Federal
University of Sao Paulo (UNIFESP), were revised and classified following
the revised diagnostic criteria. Results: Of the 140 patients, 12.85%
fulfilled the criteria for complete disease, 29.28% incomplete disease,
28.57% “probable” Vogt-Koyanagi-Harada disease and 28.27% were con-
sidered not Vogt-Koyanagi-Harada disease. Conclusion: The authors
consider that the international revised diagnostic criteria have good
applicability and are very useful to help in the diagnosis of Vogt-Koyanagi-
Harada disease.
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rapy followed by a slow tapering of the drug over 3 to 6
months. Patients who are intolerant to or with disease that is
resistant to corticosteroid therapy may be treated with immu-
nosuppressive drug therapy to minimize complications and to
improve visual prognosis(6). Intravitreal triamcinolone ace-
tonide may provide short-term improvement in visual acuity
and resolution of serous retinal detachments in patients with
VKH disease(7).
The first attempt to establish diagnostic criteria for VKH
disease took place in 1978 at the Annual Meeting of the Ame-
rican Uveitis Society(8). Because the sequential development
of these findings often makes prospective studies unfeasible,
the diagnostic criteria were revised by the First International
Workshop on VKH disease in 1999(9) (Figure 1)(9).
The new criteria take into account the multisystemic nature
of VKH disease, with allowance for the different ocular findings
that are present in the early and late stages of the disease(3).
In the present study the authors reviewed charts of pa-
tients with a previous diagnosis of Vogt-Koyanagi-Harada
disease assessing the reviewed diagnostic criteria, to check
the applicability of the revised criteria in a Brazilian VKH
disease population.
METHODS
Medical charts of 140 patients with a diagnosis of VKH
disease, from the Uveitis Sector of the Federal University of
Sao Paulo (UNIFESP), were revised and classified according
to the 2001 revised diagnostic criteria (Figure 1)(9).
A questionnaire based on the “VKH Syndrome - First
International Workshop, 1999” was filled out by the authors,
according to the information obtained from the charts.
All the patients with the diagnosis of VKH disease were
included in the study.
RESULTS
Of the total of 140 patients diagnosed as having VKH
disease, 18 (12.85%) fulfilled the criteria for complete disease,
41(29.28%) incomplete disease, 40 (28.57%) “probable” VKH
(only ocular disease) and 40 (28.27%) were considered not
having VKH disease (Figure 2), according to the 2001 revised
diagnostic criteria (Figure 1)(9).
Forty-one patients were diagnosed as having incomplete
VKH disease 27 (19.28%) with neurological findings and 14
(10%) with dermatological findings (Figure 3).
Of the 40 patients considered not having VKH, the disease
was unilateral in 4 patients (2.85%), previous ocular trauma
(surgical or not) was present in 3 patients (2.14%), presence
of another ocular or systemic disease in 5 patients (3.58%),
fundoscopy examination was impossible, due to posterior
synechiae in 22 patients (15.71%) and 7 patients (5%) simply
did not fulfill the criteria for the diagnosis of VKH disease
(Figure 4).
Figure 1 - 2001 Revised diagnostic criteria for Vogt-Koyanagi-Harada disease(9)
Complete Vogt-Koyanagi-Harada disease (criteria 1 to 5 must be present)
1. No history of penetrating ocular trauma or surgery preceding the initial onset of uveitis.
2. No clinical or laboratory evidence suggestive of other ocular disease entities.
3. Bilateral ocular involvement (a or b must be met, depending on the stage of disease when the patient is examined).
a. Early manifestations of disease. (1) There must be evidence of a diffuse choroiditis (with or without anterior uveitis, vitreous inflammatory reaction,
or optic disk hyperemia), which may manifest as one of the following:
(a) Focal areas of subretinal fluid, or
(b) Bullous serous retinal detachments.
(2) With equivocal fundus findings; both of the following must be present as well: (a) Focal areas of delay in choroidal perfusion, multifocal areas of
pinpoint leakage, large placoid areas of  hyperfluorescence, pooling within subretinal fluid, and optic nerve staining (listed in order of sequential
appearance) by fluorescein angiography, and (b). Diffuse choroidal thickening, without evidence of posterior scleritis by ultrasonography.
b. Late manifestations of disease. (1) History suggestive of prior presence of findings from 3a, and either both (2) and (3) below, or multiple signs from
(3): (2) Ocular depigmentation (either of the following manifestations is sufficient): (a) Sunset glow fundus, or (b) Sugiura sign.
(3) Other ocular signs: (a) Nummular chorioretinal depigmented scars, or (b) Retinal pigment epithelium clumping and/or migration, or (c) Recurrent
or chronic anterior uveitis.
4. Neurological/auditory findings (may have resolved by time of examination).
a. Meningismus (malaise, fever, headache, nausea, abdominal pain, stiffness of the neck and back, or a combination of these factors; headache alone
is not sufficient to meet definition of meningismus, however), or
b. Tinnitus, or
c. Cerebrospinal fluid pleocytosis.
5. Integumentary finding (not proceding onset of central nervous system or ocular disease).
a. Alopecia, or
b. Poliosis, or
c. Vitiligo,
Incomplete Vogt-Koyanagi-Harada disease (criteria 1 to 3 and either 4 or 5 must be present)
1. No history of penetrating ocular trauma or surgery preceding the initial onset of uveitis, and
2. No clinical or laboratory evidence suggestive of other ocular disease entities, and
3. Bilateral ocular involvement.
4. Neurologic/auditory findings; as defined for complete Vogt-Koyanagi-Harada disease above, or
5. Integumentary findings; as defined for complete Vogt-Koyanagi-Harada disease above.
Probable Vogt-Koyanagi-Harada disease (isolated ocular disease; criteria 1 to 3 must be present)
1. No history of penetrating ocular trauma or surgery preceding the initial onset of uveitis.
2. No clinical or laboratory evidence suggestive of other ocular disease entities.
3. Bilateral ocular involvement as defined for complete Vogt-Koyanagi-Harada disease above.
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Figure 2 - Patient distribution by revised diagnostic criteria
Figure 3 - Incomplete disease
Figure 4 - Reasons for not considering VKH disease
In Brazil, due to miscegenation it is very difficult to have a
group of patients with homogeneous racial characteristics.
Out of the 169 patients, 91.7% were considered as having VKH
disease according to the 2 criteria, 8.3% were excluded on the
basis of the revised diagnostic criteria. In conclusion, the
study document shows that the revised criteria are capable to
make a highly sensitive and specific VKH disease diagnosis.
In the present study, 29.9% of the patients did not fulfill
the diagnosis of VKH disease due to the revised criteria. If we
exclude the patients whose medical charts were incomplete,
those that do not have the fundoscopy data, 16.1% of the
patients did not fulfill the diagnosis of VKH disease according
to the revised criteria.
In this study the accordance of the former and the new
diagnosis criteria is different from that which was found in the
2 Japanese studies(10-11). A probable explanation for this fact
could be related to the homogeneity of the groups and maybe
because the Japanese studies considered different stages of
the disease.
CONCLUSION
However, the authors consider that the revised diagnostic
criteria have good sensitivity and specificity and are very
useful and applicable to help in the diagnosis of VKH disease.
RESUMO
Objetivo: Determinar a aplicabilidade do “Internacional re-
vised diagnostic criteria for Vogt-Koyanagi-Harada disease”.
Métodos: Estudo retrospectivo. Prontuários de 140 pacientes
com diagnóstico de “Vogt-Koyanagi-Harada disease”, do se-
tor de uveítes da Universidade Federal de São Paulo (UNIFESP),
foram revisados e classificados segundo o “Internacional re-
vised diagnostic criteria”. Resultados: Dos 140 pacientes,
DISCUSSION
Patients who have been previously diagnosed with VKH
disease were reclassified according to the revised diagnostic
criteria proposed by the VKH disease committee in 2001. Of
the 140 patients, VKH disease diagnosis was confirmed in 99
of them (70.71%). Among the patients in which VKH was ex-
cluded, 22 (53.65%) had no fundoscopy records in their medical
chart. Probably those patients had a late diagnosis, during the
convalescent phase of the disease.
Some authors studied the application of the revised diag-
nostic criteria in Japanese patients. Forty-nine patients were
retrospectively studied considering early and late phases of
the disease and a difference between the 2 phases was found.
In this study 6% of the patients were considered not to have
VKH disease according to the revised criteria.
In another Japanese study, Kitamura et al. compared two
different criteria for VKH disease, the revised diagnostic cri-
teria and Sugiura’s diagnosis system. The authors studied 169
patients, all of them Japanese and 56% female. The group of
patients was very homogeneous(11).
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12,85% preencheram os critérios para doença completa,
29,28% doença incompleta, 28,57% “provável” doença de
Vogt-Koyanagi-Harada e 28,27% foram consideradas como
não sendo doença de Vogt-Koyanagi-Harada. Conclusão: Os
autores consideraram que o “International revised diagnostic
criteria” tem boa aplicabilidade e é muito útil no diagnóstico da
doença de Vogt-Koyanagi-Harada.
Descritores: Síndrome uveomeningoencefálica/diagnóstico;
Técnicas de diagnóstico oftalmológico; Uveíte; Granuloma
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